Vilon
Vilon is a synthetic dipeptide (Lys-Glu) developed by the St. Petersburg Institute of Bioregulation and Gerontology. Research indicates it has strong immunomodulatory properties, stimulating thymus function, enhancing T-cell activity, and showing potential in treating immunodeficiencies and age-related immune decline.
01Dosing reference
02Mechanism of action
Chromatin Uncoiling
Vilon penetrates the cell nucleus and binds to DNA, promoting the uncoiling of chromatin in specific gene regions.
Gene Expression Modulation
This interaction stimulates the transcription of genes responsible for immune function, particularly those related to T-lymphocyte differentiation.
Immune System Activation
The resulting increase in T-cell activity and interleukin-2 production enhances the body's overall immune response and combats immunosenescence.
03Human evidence
Improved immune parameters in elderly patients, including increased T-cell counts and enhanced functional activity of immune cells.
Clinical studies conducted in Russia on older adults experiencing age-related immune decline.
Accelerated recovery and reduced complication rates in patients with secondary immunodeficiencies and chronic infections.
Observational and clinical trials in patients with compromised immune systems due to various pathologies.
04Preclinical evidence
Increased mean and maximum lifespan, along with a decreased incidence of spontaneous tumors.
Long-term studies in various strains of mice and rats evaluating geroprotective effects.
Stimulation of interleukin-2 (IL-2) production and enhanced proliferation of lymphocytes.
In vitro studies using spleen cell cultures from immunodepressed animals.
05What is known vs. unknown
- Vilon is a synthetic dipeptide consisting of L-lysine and L-glutamic acid (Lys-Glu).
- It acts primarily as an immunomodulator by stimulating T-cell immunity and thymus function.
- Animal research demonstrates significant geroprotective effects, including increased lifespan and reduced tumor incidence.
- It is part of the Khavinson peptides family, developed to regulate gene expression and cellular function.
- There is a lack of large-scale, randomized, double-blind clinical trials in Western populations.
- The long-term safety profile and optimal dosing protocols for various conditions remain under-researched outside of its origin country.
- Exact mechanisms of DNA binding and gene specificity require further molecular elucidation.
06Safety & regulatory context
07Compared with Thymalin
08Glossary
09Knowledge check
10Sources
More in Immune Support
Thymosin Alpha-1
Thymosin Alpha-1 is a naturally occurring peptide produced by the thymus gland that plays a vital role in modulating the immune system. Research demonstrates its ability to enhance T-cell function, improve vaccine response, and support the body's defense against viral infections and certain cancers.
LL-37
LL-37 is the only human cathelicidin antimicrobial peptide, naturally produced by the body's immune cells. Research shows it possesses broad-spectrum antimicrobial properties against bacteria, fungi, and viruses, while also playing a crucial role in immune modulation, reducing inflammation, and accelerating wound healing.
Vasoactive Intestinal Peptide
Vasoactive Intestinal Peptide (VIP) is a 28-amino acid neuropeptide that functions as a potent vasodilator, immune regulator, and neurotransmitter. Research highlights its ability to reduce inflammation, regulate immune responses, and improve respiratory and cardiovascular conditions.